The 20 Best Pancreatoblastoma Doctors Near Me in Lake Success, NY

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

Sepideh Gholami is a Surgical Oncologist practicing medicine in Lake Success, New York. Dr. Gholami is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Hepatectomy, and Pancreaticoduodenectomy. Dr. Gholami is board certified in American Board Of Surgery and American Board Of Surgery/Complex General Oncology.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Hepatectomy. Dr. Weiss is board certified in American Board Of Surgery.

Daniel King, MD PhD, is a gastrointestinal medical oncologist based at the Monter Cancer Center and Director of Research and Development for the Northwell Health Cancer Institute's Center for Genomic Medicine. As an academic oncologist and active researcher, he aims to deliver the latest advances uncovered through clinical trials, breakthrough technologies, and targeted therapies, to his patients. Prior to completing medical school, he pursued scientific investigation aimed at uncovering the underpinnings of cancer. These experiences included a fellowship as a Howard Hughes Research Scholar at the National Institutes of Health and as a PhD student at the Wellcome Sanger Genomic Institute at the University of Cambridge, UK, where he studied genomics and bioinformatics. More recently, Dr. King trained in medical oncology at Stanford University where he conducted translational research in pancreatic cancer and has published in peer reviewed journals. At Northwell, in addition to his active medical practice, he conducts clinical research in partnership with Cold Spring Harbor Laboratory, where he is a clinical scholar in the laboratory of Dr. Dave Tuveson. Dr. King is board certified in Internal Medicine and Medical Oncology and is an active member of the American Association of Cancer Research. Dr. King is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Ampullary Cancer, and Familial Colorectal Cancer. Dr. King is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Vinciguerra is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Colorectal Cancer. Dr. Philip is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Levy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Azriel Hirschfeld is an Oncologist practicing medicine in Bronx, New York. Dr. Hirschfeld is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Ovarian Carcinosarcoma.

Francis Arena is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Arena is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Arena is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Frank Tomao is an Oncologist and an Internal Medicine provider practicing medicine in New Hyde Park, New York. Dr. Tomao is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.

Rene Ashworth is a Hematologist and an Oncologist practicing medicine in Manhasset, New York. Dr. Ashworth is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy. Dr. Ashworth is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Joseph Herman is a Radiation Oncologist practicing medicine in New Hyde Park, New York. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatoblastoma, and Cholangiocarcinoma (Bile Duct Cancer).

Alexander Hindenburg is a Hematologist practicing medicine in Mineola, New York. Dr. Hindenburg is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy.

Michael Shusterman is an Oncologist practicing medicine in Mineola, New York. Dr. Shusterman is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Pancreatic Cancer, and Colorectal Cancer.

John Allendorf is a Surgical Oncologist practicing medicine in Mineola, New York. Dr. Allendorf is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Thyroid Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Charles Gambino is a primary care provider, practicing in Hospital Medicine in Sea Cliff, New York. Dr. Gambino is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Vitamin D Deficiency, Multisystem Inflammatory Syndrome in Children (MIS-C), Endoscopy, and Pacemaker Implantation.

Sarah Bellemare, MD, FRCS, is an attending physician in surgery and Assistant Professor of Surgery at Montefiore-Einstein. She leads the pancreas cancer tumor board at Montefiore Einstein Center for Cancer Care and is the UNOS Surgical Director of both the Live Donor Liver Transplant and Pediatric Liver Transplant Programs at Montefiore-Einstein. A recognized master surgeon, Dr. Bellemare’s clinical focus is on complex hepatobiliary and pancreatic cancer vascular reconstruction. She is also skilled in minimally invasive cancer surgery and is a core member of the multidisciplinary liver and pancreas cancer teams. Dr. Bellemare is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Liver Transplant.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.